Web Results

www.kirkland.com/sitecontent.cfm?contentID=223&itemId=3679

Dec 18, 2017 ... One of the biggest U.S. Supreme Court decisions of the past term was the court's June decision in Bristol-Myers Squibb Co. v. Superior Court of California, which severely curtailed the exercise of specific jurisdiction over out-of-state corporate defendants. 137 S. Ct. 1773 (2017). The decision has already ...

caselaw.findlaw.com/us-7th-circuit/1265038.html

Case opinion for US 7th Circuit WILLIAMS v. BRISTOL MYERS SQUIBB COMPANY. Read the Court's full decision on FindLaw.

caselaw.findlaw.com/us-1st-circuit/1533983.html

Case opinion for US 1st Circuit COLLAZO v. BRISTOL MYERS SQUIBB MANUFACTURING INC. Read the Court's full decision on FindLaw.

law.justia.com/cases/federal/appellate-courts/F3/19/1418/628272

Zenith Laboratories, Inc., Plaintiff-appellant, v. Bristol-myers Squibb Company, Defendant-appellee, 19 F.3d 1418 (Fed. Cir. 1994) case opinion from the U.S. Court of Appeals for the Federal Circuit.

www.lexology.com/library/detail.aspx?g=5dd3669c-4c36-4bff-bfbd-7466ee9c1132

Jan 5, 2018 ... On December 5, 2017, the Federal Circuit held oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, 17-1694. The case comes on appeal from an IPR decision where the Board declined to find U.S. Patent No. 8,476,239 (“the ʼ239 patent”) unpatentable as obvious. The ʼ239 ...

www.law360.com/cases/58b5b185e2b1d6689f000254

Dec 5, 2017 ... Parties, docket activity and news coverage of federal case Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, case number 17-1694, from Appellate - Federal Circuit Court.

www.law.com/njlawjournal/sites/njlawjournal/2017/12/08/personal-jurisdiction-in-the-wake-of-bristol-myers-squibb

Dec 8, 2017 ... Just this past June, in Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017) (“BMS”), the U.S. Supreme Court addressed the extent to which a defendant's forum-related contacts must relate to the plaintiff's claims in order to establish specific jurisdiction. BMS involved product liability claims ...

www.linkedin.com/in/erin-mickel-4542a69

Visiting Attorney in Kirkland & Ellis LLP's Corporate - Mergers & Acquisitions Practice. The six-month reverse secondment program concluded in October 2012 , and I returned in November 2012 to my position as Counsel, Transactional Practice Group - Bristol-Myers Squibb.